Helbig, Grzegorz, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, and Slawomira Kyrcz-Krzemien. 2015. “OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE”. Mediterranean Journal of Hematology and Infectious Diseases 7 (1):e2015003. https://doi.org/10.4084/mjhid.2015.003.